Biochemical and clinical outcomes of once-daily teriparatide in refractory chronic hypoparathyroidism: A single-center experience
Northern Clinics of Istanbul · 20.07.2026 · 336-343
DOI: 10.14744/nci.2026.03780 ↗Kurz gefasst
Fachartikel in der Zeitschrift Northern Clinics of Istanbul, erschienen am 20.07.2026. Verfasst von Aslihan Pekmezci und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Metabolism, University of Health Sciences, Basaksehir Cam and Sakura City Hospital, Istanbul, Turkiye. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Endocrinology and Metabolism, University of Health Sciences, Basaksehir Cam and Sakura City Hospital, Istanbul, Turkiye.
Zitieren
APA
Pekmezci, A., Burhan, S., Uzman Tekin, R. D., & Hatipoglu, E. (2026). Biochemical and clinical outcomes of once-daily teriparatide in refractory chronic hypoparathyroidism: A single-center experience. Northern Clinics of Istanbul, 336-343. https://doi.org/10.14744/nci.2026.03780
Vancouver
Pekmezci A, Burhan S, Uzman Tekin RD, Hatipoglu E. Biochemical and clinical outcomes of once-daily teriparatide in refractory chronic hypoparathyroidism: A single-center experience. Northern Clinics of Istanbul. 2026:336-343. doi:10.14744/nci.2026.03780
BibTeX
@article{Pekmezci2026,
author = {Pekmezci, Aslihan and Burhan, Sebnem and Uzman Tekin, Rukiye Dilara and Hatipoglu, Esra},
title = {Biochemical and clinical outcomes of once-daily teriparatide in refractory chronic hypoparathyroidism: A single-center experience},
journal = {Northern Clinics of Istanbul},
year = {2026},
pages = {336--343},
doi = {10.14744/nci.2026.03780}
}
EUVIMED